Influenza vaccine response profiles are affected by vaccine preparation and preexisting immunity, but not HIV infection

Human Vaccines and Immunotherapeutics

Volumn 11, Issue 2, 2015, Pages 391-396

  Berger, Christoph T ^a   Greiff, Victor ^b   Mehling, Matthias ^a,b   Fritz, Stefanie ^a   Meier, Marc A ^a   Hoenger, Gideon ^a   Conen, Anna ^c   Recher, Mike ^a   Battegay, Manuel ^a   Reddy, Sai T ^b   Hess, Christoph ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b ETH ZURICH   (Switzerland)

^c Infectious Disease Unit   (Switzerland)

Author keywords

HIV; Immune dysfunction; Immune response; Influenza vaccination; MBL; Unsupervised analysis; Vaccine preparation

Indexed keywords

TOXIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFLUENZA VACCINE; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN BINDING CELL; ARTICLE; BASOLATERAL MEMBRANE; CLOSTRIDIUM PERFRINGENS; CONTROLLED STUDY; ELECTRIC RESISTANCE; EPITHELIUM CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INTESTINE EPITHELIUM; LAMINA PROPRIA; NECROTIZING ENTERITIS; NONHUMAN; PROTEIN EXPRESSION; TOXICITY TESTING; WESTERN BLOTTING; ADULT; AGED; BLOOD; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; INFLUENZA A VIRUS; INFLUENZA B VIRUS; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; NORMAL HUMAN; TIME; YOUNG ADULT;

ADULT; AGED; ANTIBODIES, VIRAL; COHORT STUDIES; FEMALE; HEALTHY VOLUNTEERS; HIV INFECTIONS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA VACCINES; MALE; MIDDLE AGED; TIME FACTORS; YOUNG ADULT;

EID: 84929083020     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.1080/21645515.2015.1008930     Document Type: Article

References (25)

1. Glezen WP. Clinical practice. Prevention and treatment of seasonal influenza. N Engl J Med 2008; 359:2579-85; PMID:19073977;http://dx.doi.org/10.1056/NEJMcp0807498
2. Kwong JC, Stukel TA, Lim J, McGeer AJ, Upshur RE, Johansen H, Sambell C, Thompson WW, Thiruchelvam D, Marra F, et al. The effect of universal influenza immunization on mortality and health care use. PLoS Med 2008; 5:e211; PMID:18959473;http://dx.doi.org/10.1371/journal.pmed.0050211
3. Cox RJ, Brokstad KA, Ogra P. Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines. Scand J Immunol 2004; 59:1-15; PMID:14723616;http://dx.doi.org/10.1111/j.0300- 9475.2004.01382.x
4. DiazGranados CA, Denis M, Plotkin S. Seasonal influenza vaccine efficacy and its determinants in children and non-elderly adults: a systematic review with metaanalyses of controlled trials. Vaccine 2012; 31:49-57; PMID:23142300;http://dx.doi.org/10.1016/j.vaccine.2012.10.084
5. Bickel M, Wieters I, Khaykin P, Nisius G, Haberl A, Stephan C, Von Hentig N, Herrmann E, Doerr HW, Brodt HR, et al. Low rate of seroconversion after vaccination with a split virion, adjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected patients. AIDS 2010; 24:F31-5; PMID:20559034;http://dx.doi.org/10.1097/QAD.0b013e3283398da1
6. Fritz S, Mossdorf E, Durovic B, Zenhaeusern G, Conen A, Steffen I, Battegay M, Nuesch R, Hess C. Virosomal influenza-vaccine induced immunity in HIV-infected individuals with high versus low CD4C T-cell counts: clues towards a rational vaccination strategy. AIDS 2010; 24:2287-9; PMID:20625265;http://dx.doi.org/10.1097/QAD.0b013e32833c6f92
7. Beyer WE, Palache AM, Luchters G, Nauta J, Osterhaus AD. Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination? Virus Res 2004; 103:125-32; PMID:15163500;http://dx.doi.org/10.1016/j.virusres.2004.02.024
8. Laserson U, Vigneault F, Gadala-Maria D, Yaari G, Uduman M, Vander Heiden JA, Kelton W, Taek Jung S, Liu Y, Laserson J, et al. High-resolution antibody dynamics of vaccine-induced immune responses. Proc Natl Acad Sci U S A 2014; 111:4928-33; PMID:24639495;http://dx.doi.org/10.1073/pnas.1323862111
9. Li S, Rouphael N, Duraisingham S, Romero-Steiner S, Presnell S, Davis C, Schmidt DS, Johnson SE, Milton A, Rajam G, et al. Molecular signatures of antibody responses derived from a systems biology study of five human vaccines. Nat Immunol 2014; 15:195-204; PMID:24336226;http://dx.doi.org/10.1038/ni.2789
10. Tsang JS, Schwartzberg PL, Kotliarov Y, Biancotto A, Xie Z, Germain RN, Wang E, Olnes MJ, Narayanan M, Golding H, et al. Global analyses of human immune variation reveal baseline predictors of postvaccination responses. Cell 2014; 157:499-513; PMID:24725414;http://dx.doi.org/10.1016/j.cell.2014. 03.031
11. Bonduelle O, Yahia N, Siberil S, Benhabiles N, Carrat F, Krivine A, Rozenberg F, Dimitrov J, Kaveri SV, Curjol A, et al. Longitudinal and integrative biomodeling of effector and memory immune compartments after inactivated influenza vaccination. J Immunol 2013; 191:623-31; PMID:23776176;http://dx.doi.org/10.4049/jimmunol.1203483
12. Chang WC, White MR, Moyo P, McClear S, Thiel S, Hartshorn KL, Takahashi K. Lack of the pattern recognition molecule mannose-binding lectin increases susceptibility to influenza A virus infection. BMC Immunol 2010; 11:64; PMID:21182784;http://dx.doi.org/10.1186/1471-2172-11-64
13. Ruseva M, Kolev M, Dagnaes-Hansen F, Hansen SB, Takahashi K, Ezekowitz A, Thiel S, Jensenius JC, Gadjeva M. Mannan-binding lectin deficiency modulates the humoral immune response dependent on the genetic environment. Immunology 2009; 127:279-88; PMID:19476514; http://dx.doi.org/10.1111/j.1365-2567.2008.03016.x
14. Mehling M, Hilbert P, Fritz S, Durovic B, Eichin D, Gasser O, Kuhle J, Klimkait T, Lindberg R, Kappos L, et al. Antigen-specific adaptive immune responses in fingolimod-treated MS patients. Annals of Neurology 2011 69(2):408-13; PMID:21387383;http://dx.doi.org/10.1002/ana.22352
15. Berger CT, Frahm N, Price DA, Mothe B, Ghebremichael M, Hartman KL, Henry LM, Brenchley JM, Ruff LE, Venturi V, et al. High-functional-avidity cytotoxic T lymphocyte responses to HLA-B-restricted Gagderived epitopes associated with relative HIV control. J Virol 2011; 85:9334-45; PMID:21752903;http://dx. doi.org/10.1128/JVI.00460-11
16. Dietz A, Gustafson MP, Lin Y, LaPlant BR, Liwski CJ, Maas ML, League SC, Bauer PR, Abraham RS, Tollefson MK, et al. Immune monitoring using the predictive power of immune profiles. Cytotherapy 2013; 15: S48-S; http://dx.doi.org/10.1016/j.jcyt.2013.01.183
17. Muraro PA, Robins H, Malhotra S, Howell M, Phippard D, Desmarais C, Sousa ADA, Griffith LM, Lim N, Nash RA, et al. T cell repertoire following autologous stem cell transplantation for multiple sclerosis. Journal of Clinical Investigation 2014; 124:1168-72; PMID:24531550;http://dx.doi.org/10.1172/JCI71691
18. Nagalla S, Chou JW, Willingham MC, Ruiz J, Vaughn JP, Dubey P, Lash TL, Hamilton-Dutoit SJ, Bergh J, Sotiriou C, et al. Interactions between immunity, proliferation and molecular subtype in breast cancer prognosis. Genome Biol 2013; 14(4):R34; PMID:23618380; http://dx.doi.org/10.1186/gb-2013- 14-4-r34
19. Suzuki R, Shimodaira H. Pvclust: an R package for assessing the uncertainty in hierarchical clustering. Bioinformatics 2006; 22:1540-2; PMID:16595560;http://dx.doi.org/10.1093/bioinformatics/btl117
20. Worthley DL, Bardy PG, Gordon DL, Mullighan CG. Mannose-binding lectin and maladies of the bowel and liver. World J Gastroenterol 2006; 12:6420-8; PMID:17072973
21. Buricchi F, Bardelli M, Malzone C, Capecchi B, Nicolay U, Fragapane E, Castellino F, Del Giudice G, Galli G, Finco O. Impact of preexisting memory to seasonal A/H1N1 influenza virus on the immune response following vaccination against avian A/H5N1 virus. Eur J Immunol 2013; 43:641-8; PMID:23238926;http://dx.doi.org/10.1002/eji.201242563
22. Houser KV, Pearce MB, Katz JM, Tumpey TM. Impact of prior seasonal H3N2 influenza vaccination or infection on protection and transmission of emerging variants of influenza A(H3N2)v virus in ferrets. J Virol 2013; 87:13480-9; PMID:24089569;http://dx. doi.org/10.1128/JVI.02434-13
23. Pandey A, Singh N, Vemula SV, Couetil L, Katz JM, Donis R, Sambhara S, Mittal SK. Impact of preexisting adenovirus vector immunity on immunogenicity and protection conferred with an adenovirus-based H5N1 influenza vaccine. PLoS One 2012; 7:e33428; PMID:22432020;http://dx.doi.org/10.1371/journal. pone.0033428
24. Launay O, van der Vliet D, Rosenberg AR, Michel ML, Piroth L, Rey D, Colin de Verdiere N, Slama L, Martin K, Lortholary O, et al. Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial. JAMA 2011; 305:1432-40; PMID:21486976;http://dx.doi.org/10.1001/jama.2011.351
25. McKittrick N, Frank I, Jacobson JM, White CJ, Kim D, Kappes R, DiGiorgio C, Kenney T, Boyer J, Tebas P. Improved immunogenicity with high-dose seasonal influenza vaccine in HIV-infected persons: a single-center, parallel, randomized trial. Ann Intern Med 2013; 158:19-26; PMID:23277897; http://dx.doi.org/10.7326/0003-4819-158-1-201301010-00005